194 related articles for article (PubMed ID: 29338993)
1. Peritoneal sarcomatosis 5 years after laparoscopic morcellation of uterine leiomyoma.
Petrillo M; Dessole M; Chiantera V
Am J Obstet Gynecol; 2018 Jun; 218(6):626. PubMed ID: 29338993
[No Abstract] [Full Text] [Related]
2. Low-Grade Endometrial Stromal Sarcoma Diagnosed 8 Years After Hysterectomy With Morcellation.
Sanneh A; Murdock T; Wethington SL; Fader AN; Xing D; Beavis AL
Obstet Gynecol; 2020 Aug; 136(2):365-368. PubMed ID: 32649495
[TBL] [Abstract][Full Text] [Related]
3. A Multicentre Retrospective Review of Clinical Characteristics of Uterine Sarcoma.
Wais M; Tepperman E; Bernardini MQ; Gien LT; Jimenez W; Murji A
J Obstet Gynaecol Can; 2017 Aug; 39(8):652-658. PubMed ID: 28729098
[TBL] [Abstract][Full Text] [Related]
4. Nonmalignant Sequelae of Unconfined Morcellation at Laparoscopic Hysterectomy or Myomectomy.
Tulandi T; Leung A; Jan N
J Minim Invasive Gynecol; 2016; 23(3):331-7. PubMed ID: 26802909
[TBL] [Abstract][Full Text] [Related]
5. Effects of morcellation of uterine smooth muscle tumor of uncertain malignant potential and endometrial stromal sarcoma: case series and recommendations for clinical practice.
Mowers EL; Skinner B; McLean K; Reynolds RK
J Minim Invasive Gynecol; 2015; 22(4):601-6. PubMed ID: 25596464
[TBL] [Abstract][Full Text] [Related]
6. Endometrial stromal sarcoma diagnosed after uterine morcellation in laparoscopic supracervical hysterectomy.
Della Badia C; Karini H
J Minim Invasive Gynecol; 2010; 17(6):791-3. PubMed ID: 20955991
[TBL] [Abstract][Full Text] [Related]
7. Risk of Undetected Cancer at the Time of Laparoscopic Supracervical Hysterectomy and Laparoscopic Myomectomy: Implications for the Use of Power Morcellation.
Perkins RB; Handal-Orefice R; Hanchate AD; Lin M; Paasche-Orlow MK
Womens Health Issues; 2016; 26(1):21-6. PubMed ID: 26701205
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of occult pre-malignant or malignant pathology at the time of uterine morcellation for benign disease.
Von Bargen EC; Grimes CL; Mishra K; Wang R; Haviland MJ; Hacker MR; Carnevale JA; Estes AJ; Elkadry EA
Int J Gynaecol Obstet; 2017 May; 137(2):123-128. PubMed ID: 28170091
[TBL] [Abstract][Full Text] [Related]
9. Association Between Power Morcellation and Mortality in Women With Unexpected Uterine Cancer Undergoing Hysterectomy or Myomectomy.
Xu X; Lin H; Wright JD; Gross CP; Boscoe FP; Hutchison LM; Schwartz PE; Desai VB
J Clin Oncol; 2019 Dec; 37(35):3412-3424. PubMed ID: 31518176
[TBL] [Abstract][Full Text] [Related]
10. Malignancy rate of 10,731 uteri morcellated during laparoscopic supracervical hysterectomy (LASH).
Bojahr B; De Wilde RL; Tchartchian G
Arch Gynecol Obstet; 2015 Sep; 292(3):665-72. PubMed ID: 25820974
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics and management experience of unexpected uterine sarcoma after myomectomy.
Zhang J; Zhang J; Dai Y; Zhu L; Lang J; Leng J
Int J Gynaecol Obstet; 2015 Aug; 130(2):195-9. PubMed ID: 26117552
[TBL] [Abstract][Full Text] [Related]
12. Risk of Occult Uterine Sarcoma in Presumed Uterine Fibroids.
Cui RR; Wright JD
Clin Obstet Gynecol; 2016 Mar; 59(1):103-18. PubMed ID: 26645385
[TBL] [Abstract][Full Text] [Related]
13. Clinical Characteristics and Prognosis of Unexpected Uterine Sarcoma After Hysterectomy for Presumed Myoma With and Without Transvaginal Scalpel Morcellation.
Zhang J; Li T; Zhang J; Zhu L; Lang J; Leng J
Int J Gynecol Cancer; 2016 Mar; 26(3):456-63. PubMed ID: 26807642
[TBL] [Abstract][Full Text] [Related]
14. Incidence of Occult Uterine Malignancy Following Vaginal Hysterectomy With Morcellation.
Wasson M; Magtibay P; Magtibay P; Magrina J
J Minim Invasive Gynecol; 2017; 24(4):665-669. PubMed ID: 28254678
[TBL] [Abstract][Full Text] [Related]
15. Peritoneal Washings After Power Morcellation in Laparoscopic Myomectomy: A Pilot Study.
Toubia T; Moulder JK; Schiff LD; Clarke-Pearson D; O'Connor SM; Siedhoff MT
J Minim Invasive Gynecol; 2016; 23(4):578-81. PubMed ID: 26867701
[TBL] [Abstract][Full Text] [Related]
16. Assessing the risk of laparoscopic morcellation of occult uterine sarcomas during hysterectomy and myomectomy: Literature review and the ISGE recommendations.
Sizzi O; Manganaro L; Rossetti A; Saldari M; Florio G; Loddo A; Zurawin R; van Herendael B; Djokovic D
Eur J Obstet Gynecol Reprod Biol; 2018 Jan; 220():30-38. PubMed ID: 29149644
[TBL] [Abstract][Full Text] [Related]
17. Iatrogenic parasitic leiomyoma and leiomyomatosis peritonealis disseminata following uterine morcellation.
Lu B; Xu J; Pan Z
J Obstet Gynaecol Res; 2016 Aug; 42(8):990-9. PubMed ID: 27125448
[TBL] [Abstract][Full Text] [Related]
18. Long-term sequelae of unconfined morcellation during laparoscopic gynecological surgery.
Cohen A; Tulandi T
Maturitas; 2017 Mar; 97():1-5. PubMed ID: 28159054
[TBL] [Abstract][Full Text] [Related]
19. Risk of morcellation of uterine leiomyosarcomas in laparoscopic supracervical hysterectomy and laparoscopic myomectomy, a retrospective trial including 4791 women.
Lieng M; Berner E; Busund B
J Minim Invasive Gynecol; 2015; 22(3):410-4. PubMed ID: 25460521
[TBL] [Abstract][Full Text] [Related]
20. Power morcellation-induced dissemination of sarcomatous component arising in leiomyoma.
Emoto I; Moriuchi K; Kanbayashi S; Inohaya A; Ri Y; Sato Y
J Obstet Gynaecol Res; 2018 Sep; 44(9):1843-1849. PubMed ID: 29974551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
